Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples

BACKGROUND: An increasing number of anti-cancer therapeutic agents target specific mutant proteins that are expressed by many different tumor types. Successful use of these therapies is dependent on the presence or absence of somatic mutations within the patient’s tumor that can confer clinical effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Toomey, Sinead, Carr, Aoife, Mezynski, Mateusz Janusz, Elamin, Yasir, Rafee, Shereen, Cremona, Mattia, Morgan, Clare, Madden, Stephen, Abdul-Jalil, Khairun I., Gately, Kathy, Farrelly, Angela, Kay, Elaine W., Kennedy, Susan, O’Byrne, Kenneth, Grogan, Liam, Breathnach, Oscar, Morris, Patrick G., Eustace, Alexander J., Fay, Joanna, Cummins, Robert, O’Grady, Anthony, Kalachand, Roshni, O’Donovan, Norma, Kelleher, Fergal, O’Reilly, Aine, Doherty, Mark, Crown, John, Hennessy, Bryan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036178/
https://www.ncbi.nlm.nih.gov/pubmed/32087721
http://dx.doi.org/10.1186/s12967-020-02273-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036178/
https://www.ncbi.nlm.nih.gov/pubmed/32087721
http://dx.doi.org/10.1186/s12967-020-02273-4

Ejemplares similares